Метаболічні порушення у хворих на гіпертонічну хворобу, хронічне обструктивне захворювання легень та особливості їх поєднаного перебігу (огляд літератури)

S. V. Biletskyi, V. V. Boyko, M. P. Sumariuk

Анотація


У роботі аналізуються дані літератури про метаболічні порушення у хворих на гіпертонічну хворобу, хронічне обструктивне захворювання легень та за їх поєднаного перебігу.


Ключові слова


гіпертонічна хвороба; хронічне обструктивне захворювання легень; метаболічні порушення

Повний текст:

PDF

Посилання


Bobrov VA, Firsova IG. Metabolizm oksida azota i endotelial'naya disfunktsiya u bol'nykh s essentsial'noy gipertenziey s priznakami remodelirovaniya levogo zheludochka [Nitric oxide metabolism and endothelial dysfunction in patients with essential hypertension with signs of remodeling of the left ventricle]. Ukr. kardiol. zh. 2010;3:58-3. (in Russian).

Voloshina IN. Vzaimosvyaz' provospalitel'noy aktivatsii s tyazhest'yu arterial'noy gipertenzii i vozmozhnosti medikamentoznoy korrektsii [Interrelation of proinflammatory activation with severity of arterial hypertension and the possibility of drug correction]. Zaporozh. med. zh. 2010;12:18-2. (in Russian).

Deyneha VH, Kryvenko VV. Osoblyvosti morfofunktsional'noho stanu sertsya, sudyn ta endotelial'noyi funktsiyi v osib iz poyednanym perebihom khronichnoho obstruktyvnoho zakhvoryuvannya lehen' ta hipertonichnoyi khvoroby [Features of the morphofunctional state of the heart, blood vessels and endothelial function in persons with a combined course of chronic obstructive lung disease and hypertension]. Buk. med. visnyk. 2013;17(2):41-5. (in Ukrainian).

Zagidullin NSh, Valeeva KF, Gassanov N. Znachenie disfunktsii endoteliya pri serdechno-sosudistykh zabolevaniyakh i metody ee medikamentoznoy korrektsii [The importance of endothelial dysfunction in cardiovascular diseases and methods of its medicamental correction]. Kardiologiya. 2010;5:54-60. (in Russian).

Kramareva VN. Funktsiya endoteliya u bol'nykh s essentsial'noy arterial'noy gipertenziey s razlichnymi urovnyami serdechno-sosudistogo riska [Endothelial function in patients with essential hypertension with different levels of cardiovascular risk]. Ukr. kardiol. zh. 2010;2:43-5. (in Russian).

Kryvenko VV. Systemne zapalennya ta morfofunktsional'ni parametry miokarda i sudyn u khvorykh z poyednanym perebihom khronichnoho obstruktyvnoho zakhvoryuvannya lehen' i hipertonichnoyi khvoroby [Systemic inflammation and morphofunctional parameters of the myocardium and vessels in patients with a combined course of chronic obstructive pulmonary disease and hypertension]. Zaporozh. med. zh. 2013;3:43-6. (in Ukrainian).

Mangileva TA. Arterial'naya gipertenziya pervoy stepeni, giperinsulinemiya i ozhirenie. [Arterial hypertension of the first degree, hyperinsulinemia and obesity]. Sertse i sudyny. 2010;2:77-1. (in Russian).

Sirenko YuM, Rekovets' OL, Savyts'kyy SYu. Metabolichnyy syndrom u patsiyentiv z arterial'noyu hipertenziyeyu ta metabolichni efekty riznykh antyhipertenzyvnykh preparativ [Metabolic syndrome in patients with arterial hypertension and the metabolic effects of various antihypertensive drugs]. Arterial. gipertenziya. 2010;4. Available from: http://www.mif-ua.com/archive/article/13618(24.01.2013). (in Ukrainian).

Mychka VB, Chazova IE. Medikamentoznaya korrektsiya narusheniy uglevodnogo obmena: snizhenie riska serdechno-sosudistykh oslozhneniy [Medication correction of carbohydrate metabolism disorders: reduction of risk of cardiovascular complications]. Available from: http://medi.ru/doc/260906.htm (15.11.2009). (in Russian).

Nakaz MOZ Ukrayiny № 384 vid 24.05.2012. Arterial'na hipertenziya. Onovlena ta adaptovana klinichna nastanova, zasnovana na dokazakh [Arterial hypertension. Updated and adapted clinical instruction based on evidence]. (in Ukrainian).

Paranich AV, Lad SN, Frolova NA. O patogeneticheskom znachenii narusheniy sostoyaniya antiokislitel'nogo gomeostaza u bol'nykh gipertonicheskoy bolezn'yu [On pathogenetic significance of disorders of state antioxidant homeostasis in patients with essential hypertension]. Available from: http://medi.ru/PBMC/ 8800606.htm (25.06.2009). (in Russian).

Ostrovs'kyy MM, Herych PR. Do pytannya polimorbidnosti ta komorbidnosti u khvorykh na KhOZL [On the issue of poliomybery and comorbidity in patients with COPD]. Ukr. pul'monol. zh. 2011;4:19-4. (in Ukrainian).

Petrynych OA. Osoblyvosti metabolichnykh pokaznykiv u khvorykh na hipertonichnu khvorobu ta v poyednanni z tsukrovym diabetom 2-ho typu zalezhno vid rivnya insulinemiyi [Features of metabolic indicators in patients with hypertension and in combination with type 2 diabetes, depending on the level of insulinemia]. Buk. med. visnyk. 2013;17(3):176-80. (in Ukrainian).

Petrynych OA. Peroksydne okysnennya lipidiv y antyoksydantnyy zakhyst u khvorykh na hipertonichnu khvorobu ta u poyednanni z tsukrovym diabetom typu 2 [Peroxide lipid oxidation and antioxidant defense in patients with hypertension and in combination with type 2 diabetes]. Klin. ta eksperym. patol. 2009;8(3):74-8. (in Ukrainian).

Bilets'kyy SV, Koval'chuk LYu, Petrynych OA. Pokaznyky prooksydantno-antyoksydantnoho homeostazu ta vmist monooksydu nitrohenu u krovi khvorykh na hipertonichnu khvorobu v poyednanni z ishemichnoyu khvoroboyu sertsya [Indicators of prooxidant antioxidant homeostasis and the content of nitrogen monoxide in the blood of patients with hypertension in combination with ischemic heart disease]. Buk. med. visnyk. 2013;17(3):125-28. (in Ukrainian).

Svishchenko EP, Kovalenko VN. Arterial'naya gipertenziya [Arterial hypertension]. Arterial. gipertenziya.Kiev; 2001. 502 р. (in Russian).

Mkhitaryan LS, Orlova NN, Evstratova IN. Sostoyanie svobodnoradikal'nykh okislitel'nykh protsessov v usloviyakh dlitel'nogo techeniya gipertonicheskoy bolezni [The state of free radical oxidation processes in conditions of prolonged course of hypertensive disease]. Ukr. kardiol. zh. 2009;2:34-8. (in Russian).

Kovalenko VM, editor. Stan zdorov"ya narodu Ukrayiny u zv"yazku iz khvorobamy systemy krovoobihu ta mozhlyvi shlyakhy yoho pokrashchannya. Analityko-statystychnyy posibnyk dlya likariv [The state of health of the people ofUkrainein connection with illnesses circulatory system and possible ways to improve it. Analytical and statistical manual for doctors]. Kiev; 2004. 124 р. (in Ukrainian).

Lyusov VA, Metel'skaya VA, Oganov RG. Uroven' oksida azota v syvorotke perifericheskoy krovi bol'nykh s razlichnoy tyazhest'yu arterial'noy gipertenzii [The level of nitric oxide in the serum of peripheral blood of patients with different severity of arterial hypertension]. Kardiologiya. 2011;12:23-8. (in Russian).

Feshchenko YuI. Aktual'ni problemy diahnostyky i terapiyi KhOZL iz suputn'oyu patolohiyeyu [Actual problems of diagnostics and therapy of COPD with concomitant pathology]. Ukr. pul'monol. zh. 2009;2:6. (in Ukrainian).

Yachnyk AI. KhOZL i hipertonichna khvoroba: stan problemy i suchasni pidkhody do terapiyi [COPD and hypertension: state of the problem and modern approaches to therapy]. Ukr. pul'monol. zh. 2009;2:9. (in Ukrainian).

Barnes PJ, Cosio MG. Cells and mediators of chronic obstructive pulmonary disease. Eur. Respir. Monogr. 2006;38:130-58.

Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. American Journal of Hypertension. 2000;13(6):S112-S122.

Falk JA, Kadiev S, Criner GJ. Cardiac disease in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2008;5:543-48.

Divo M, Cote C, Torres JP. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 2012;186:155-61.

Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch. Intern. Med. 2009;169:155-62.

Rabe KF. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care. Med. 2007;176:532-55.

Granger JP. An emerging role for infl ammatory cytokines in hypertension. Am. J. Physiol. Heart. Circ. Physiol. 2006;290:923-24.

Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128:2640-646.

La Marca BB, Bennett WA, Alexander BT. Hypertension produced by reduction in uterine perfusion in the pregnant rat: role of tumor necrosis factor-α. Hypertension. 2005;46:1022-025.

Calabrese F, Baraldo S, Bazzan E. IL-32, anovel proinfl ammatory cytokine in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med. 2008;178:894-901.

Viel EC, Lemarie CA, Benkirane K. Immune regulation and vascular inflammation in genetic hypertension. Am. J. Physiol. Heart. Circ. Physiol. 2010;298:938-44.

Harrison DG, Guzik TJ, Lob HE. Inflammation, immunity, and hypertension. Hypertension. 2011;57:132-40.

Jeppesen J, Hein HO, Suadicani P. Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch. Int. Med. 2001;161(3):361-66.

Zavaroni I, Mazza S, Dall E. Aglio Prevalence of hyperinsulinaemia in patients with high blood pressure. J. Intern. Med. 1992;231(3):235-40.

Romero JC. Role of angiotensine and oxidative stress in essential hypertension. Hypertension. 1999;34:943-49.

Savage D, Petersen KF, Shuiman GI. Mechanisms of insulin resistance in human and possible links with inflammation. Hypertension. 2005;45:828-36.

The IDF consensus worldwide definition of the metabolic Syndrome. Diabetic Мedicine. 2006;23:469-80.

Yao H, Rahman I. Current concepts on oxidative/carbonyl stress, infl ammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicology and Applied Pharmacology. 2011;254:72-5.


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24061/113751

Посилання

  • Поки немає зовнішніх посилань.


Copyright (c) 2017 S. V. Biletskyi, V. V. Boyko, M. P. Sumariuk

Технічний редактор журналу, к.мед.н. М. Степанченко, 2015-2017